Home › Multiple Sclerosis › NCT04603196

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Written consent
* Over age 18
* Confirmed diagnosis of multiple sclerosis

Exclusion Criteria:

* cannot provide informed consent

About the study

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Sponsor: Beth Israel Deaconess Medical Center · Participants: 800 · Started: Jun 20, 2019

Contact the study team

• Jacob A Sloane, MD, PhD · Phone: 6176673726

Official record on ClinicalTrials.gov — NCT04603196

Locations in the U.S.

Conditions

• Multiple Sclerosis
• Obstructive Sleep Apnea

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.